Jill Zouzoulas, MD, FACR, Tryon Medical Partners

An expert in the field of rheumatology predicts how the treatment landscape will evolve for intravenous and subcutaneous therapies.

Jill Zouzoulas, M.D., FACR, describes the best practices for incorporating patient perspectives when determining the ideal route of administration for those with rheumatologic diseases.

An expert rheumatologist highlights the billing process for patients receiving biologic therapies, as well as a study that highlights patient reported outcomes in patients with inflammatory arthritis utilizing intravenous biologics.

Dr. Zouzoulas discusses key patient considerations to consider when deciding on an intravenous or subcutaneous biologic.

A medical expert shares critical insights around biologic utilization.

Jill Zouzoulas, MD, FACR, opens a discussion highlighting use of biologics in her practice.